A- A A+
NIPER
HAJIPUR

Dr. Sanjiv Singh

Dr. Sanjiv Singh

Assistant Professor

Department: Pharmacology and Toxicology

Institute: National Institute of Pharmaceutical Education & Research (NIPER),
Hajipur-844101, Bihar, India.

Mobile: +91-738918414

Email: sanjivsingh[at]niperhajipur[dot]ac[dot]in
sanjivpg2006[at]gmail[dot]com

Date of Joining (DOJ): 20/09/2018

Dr. Sanjiv Singh

Faculty CV

  • 2013: Ph.D. (Pharmaceutical Science), Vinayaka Mission’s Research Foundation University (VMRFDU).
  • 2006: M.Pharm. (Pharmacology), Rajiv Gandhi University of Health Sciences, Bengaluru.
  • 2003: B.Pharm., Rajiv Gandhi Proudyogiki Vishwavidyalaya, Bhopal, Madhya Pradesh.

  • Exploring the potential of herbal antioxidants in management of cardiovascular disorders including atherosclerosis and ageing.
  • Protective role of herbal antioxidants against pesticide and nanoparticle-induced neurotoxicity.
  • Neuroinflammation with emphasis on Nrf2-HO1 and Inflammasome pathways.

  • Assistant Professor, Department of Pharmacology & Toxicology, NIPER Hajipur (September 2018 – Present).
  • Assistant Professor, Department of Pharmacology & Toxicology, NIPER Raebareli (August 2015 – August 2018).
  • Associate Professor, TIP Bhopal (January 2013 – July 2015).

  1. 2021 – “Aroma inhalation apparatus for small animals to be used in Pharmacological evaluation of aromatic substances.”Indian Patent Application No. 202131019201A.
  2. 2020 – “Device for blood withdrawal from saphenous vein of mice for pharmacological research experiments.”Indian Patent Application No. 202031051834.
  3. 2010 – “Multipurpose Herbal Compositions of Annona Squamosa and Nigella Sativa.”Indian Patent Application No. 2509/MUM/2010.

  • Research Project funded by Madhya Pradesh Council of Science and Technology on Mobile Phone Effects.
  • Life Member, Indian Pharmacy Graduate Association (LM-5430).
  • Life Member, Association of Pharmaceutical Teachers of India (MP/LM-187).
  • Registered Pharmacist, Madhya Pradesh Pharmacy Council of India (Reg. No. 15450).

  1. Mhaske, A., Singh, S., Abourehab, M. A., Kumar, A., Kesharwani, P., & Shukla, R.(2022).Recent pharmaceutical engineered trends as theranostics for Japanese Encephalitis. Process Biochemistry.(Elsevier)
  2. Madhu, M., Udaya Kumar, V., Dhingra, S., Kumar, N., Singh, S., Ravichandiran, V.,& Murti, K. (2022). Nutritional Aspects of People Living with HIV (PLHIV) AmidstCOVID-19 Pandemic:anInsight.Currentpharmacologyreports,1-15.(Springer Nature)
  3. Singh,S.,Siva,B.V.,& Ravichandiran,V.2022). Advanced Glycation End Products: key player of the pathogenesis of atherosclerosis. Glycoconjugate Journal,1-17.(Springer Nature)
  4. Choudhary, A., Singh, S., & Ravichandiran, V. (2022). Toxicity, preparation methods and applications of Silver Nanoparticles: an update. Toxicology Mechanisms andMethods,1-12. (Taylor & Francis)
  5. Alshammari, A., Alharbi, M., Albekairi, N. A., Albekairi, T. H., Alharbi, O. O.,Yeapuri, P., & Singh, S. (2022). Protective Effect of CP690550 in MPTP-InducedParkinson’sLikeBehavioural,BiochemicalandHistologicalAlterationsinMice.NeurotoxicityResearch,40(2), 564-572. (Springer Nature)
  6. Xavier,J.,Singh,S.,Kumari,P.,& Ravichandiran,V.(2022). Neurological repercussions of neonatal nicotine exposure: A review. International Journal of Developmental Neuroscience, 82(1), 3-18. (Wiley Society Publishing)
  7. Lingamaiah,D.,NS,S.,Murti,K.,Singh,S.,Ravichandiran,V.,&Dhingra,S.(2022).Emicizumab:anFDA-ApprovedMonoclonalAntibodyintheTreatmentofHemophilia A.CurrentPharmacologyReports,1-9.(Springer Nature)
  1. Singh,S.,Changkija,S.,Mudgal,R.,&Ravichandiran,V.2022).Bioactive components to inhibit foam cell formation in atherosclerosis. Molecular Biology Reports,1-15. (Springer Nature)
  2. Handa, M., Aparnasai, R. G., Panicker, N., Singh, S., & Ruwali, M. (2022). Recenttrends of extracellular vesicles for therapeutic intervention of brain-related diseases. InNanomedicalDrugDeliveryforNeurodegenerativeDiseases(pp.119-128).(AcademicPress).
  3. S Singh, P Agarwal,V Ravichandiran (2021) Two-Pore Domain Potassium Channel in Neurological Disorders. The Journal of Membrane Biology 254(4),367-380.(Springer Nature)
  4. S Singh,A Dixit,V Ravichandiran (2021 ) MCP-1:Function, Regulation, and Involvement in Disease. International Immunopharmacology, 107598.(Elsevier)
  5. Meghana, A., Obulapathi, U., & Singh, S. (2021). Indian cow urine as a therapeuticalternative in treatment of human diseases: A review. AYUHOM, 8(2), 57. (officialpublicationofNorthEasternInstituteof Ayurveda&Homoeopathy (NEIAH))
  6. Sanjiv Singh, Devarapati Nagalakshmi, K.K.Sharma, V.Ravichandiran (2021) Natural antioxidants for neuroinflammatory disorders and possible involvemen to fNrf2pathway:Areview.7(2);e06216.(Elsevier).
  7. Munindra Ruwali, Keshav Moharir, Sanjiv Singh, Punita Aggarwal, Manash Paul(2021)UpdatesinpharmacogeneticsofNon-smallcelllungcancer.Pharmacogenetics,(In-print)(IntechOpen)
  8. Sanjiv Singh, Punita Aggarwal, Velayutham Ravichandiran (2021) ImmunologicalresponseoftherespiratorytractintheSARS-CoV-2infection.Coronaviruses.(InPrint)(BenthamScience)
  9. Shantanu Singh, Chandan Chauhan, Anshita, Sachin Kumar, Sanjiv Singh(2021) Natural Antioxidants: Potential Oxidative Stress Inhibitors for the Treatment of Asthma.  International Journal of Research in Pharmacology & Pharmacotherapeutics.10:48-53.
  1. J Ahmad,S Amin,S Singh,G Mustafa,MA Barkat(2020) Self Nano emulsifying Drug Delivery System for Improving Efficacy of Bioactive Phytochemicals. Nanophytomedicine71-87.(Springer Nature)
  2. Sanjiv Singh, Upendr Gautam, FV Manvi (2020) Protective Impact of Edaravone Against ZnO NPs-induced Oxidative Stress in the Human Neuroblastoma SH-SY5YCellLine.Cellular and Molecular Neurobiology.(In-print)(SpringerNature)
  3. Sanjiv Singh, Shantanu Singh (2020) JAK-STAT inhibitors: Immersing therapeuticapproachformanagementofrheumatoidarthritis.Internationalimmunopharmacology.86;106731.(Elsevier)
  4. Sanjiv Singh, Avtar Singh Gautam (2019) Upregulated LOX-1 Receptor: Key PlayerofthePathogenesisofAtherosclerosis.CurrentAtherosclerosisReports.21:38.(Springer Nature)
  5. Sanjiv Singh, Amit Pawar (2019) Effect of radio frequency electromagnetic field frommobile phones’ base station antennas on maturation of rat erythrocytes. ComparativeClinicalPathology.22:14. (SpringerNature)
  6. SanjivSingh,AbhishekKumar(2019)ProtectiveEffectofEdaravoneonCyclophosphamide Induced Oxidative Stress and Neurotoxicity in Rats. Current DrugSafety.14. (BenthamScience)
  7. Sanjiv Singh (2019) Herbal Approach for Management of Atherosclerosis: a Review.CurrentAtherosclerosisReports. 21:12. (Springer Nature)
  8. SanjivSingh(2018)Zincoxidenanoparticlesimpacts:cytotoxicity,genotoxicity,developmentaltoxicity,andneurotoxicity.ToxicologyMechanismsandMethods12:03.(Taylor&Francis)
  9. SanjivSingh,RahulShukla(2018)KeySignalingPathwaysEngagedinCancerManagement: Current Update. Current Cancer Therapy Reviews 14, 1-13. (BenthamScience)
  10. Sanjiv Singh, SJS Flora (2018) Key Factor Associated With Cancer Progression: AReview.JournalofCellandTissueResearch.18(1):6355-6360.(CTR Publications)
  11. Sanjiv singh, HS Chandel, Sujeet Kushwaha(2015)evaluation of Anti diabetic activity of trace elements. American Chemical Science Journal. 6(1):25-37.(Science domain)
  12. H S Chandel, Sanjiv singh, Ravi kushwaha (2013) Evaluation of antiarthritic activity on Luffa echinata Roxb. fruits on rats.”Asian Journal of Biomedical&PharmaceuticalSciences3(21):36-41.(Allied Academies)